Innovassynth Technologies (India) Share Price

Investment Companies company Innovassynth Technologies (India) announced Q4FY26 & FY26 results Financial Highlights: The company recorded a Total Income of Rs 5,094.67 lakh for Q4FY26, representing an increase of 130.76% from Rs 2,207.78 lakh in Q3FY26 (QoQ) and a growth of 4.01% from Rs 4,898.42 lakh in Q4FY25 (YoY). Revenue from operations for Q4FY26 stood at Rs 5,082.67 lakh, marking a sequential increase of 131.32% compared to Rs 2,197.24 lakh in Q3FY26. On a year-on-year basis, revenue grew by 5.00% from Rs 4,840.66 lakh in Q4FY25. For FY26, the company reported total Revenue from operations of Rs 10,235.21 lakh, an increase of 4.11% compared to Rs 9,831.35 lakh in FY25. Annual Total Income reached Rs 10,295.93 lakh, up by 2.87% from Rs 10,009.07 lakh in FY25. Net Profit for Q4FY26 was Rs 1,195.13 lakh, a turnaround from a Net Loss of Rs 779.72 lakh in Q3FY26. Compared to Q4FY25, the Net Profit increased by 2.78% from Rs 1,162.86 lakh. For FY26, the company incurred an annual Net Loss of Rs 2,878.80 lakh, as against a Net Profit of Rs 2,014.50 lakh in FY25. Total Comprehensive Income for Q4FY26 was Rs 1,210.27 lakh, compared to a comprehensive loss of Rs 764.43 lakh in Q3FY26 and a comprehensive profit of Rs 1,180.85 lakh in Q4FY25. The annual Total Comprehensive Loss for FY26 stood at Rs 2,848.37 lakh, as against a comprehensive income of Rs 2,004.64 lakh in FY25. The Basic and Diluted Earnings Per Share (EPS) for Q4FY26 was Rs 1.58, compared to negative Rs 1.03 in Q3FY26 and Rs 1.54 in Q4FY25. For FY26, the EPS was negative Rs 3.82, compared to Rs 4.05 in FY25. Business Highlights: Merger and Corporate Name Change: The company completed the merger by absorption of its associate, Innovassynth Technologies (India) Limited ("ITIL"), with an appointed date of October 01, 2024. Following the merger becoming effective on December 19, 2025, the name of the company was officially changed from Innovassynth Investments Limited to Innovassynth Technologies (India) Limited. Rights Issue Allotment: The company completed the allotment of 1,74,11,380 equity shares on a rights basis on May 19, 2026. The shares were issued at a price of Rs 40 per share (including a premium of Rs 30), aggregating to Rs 6,964.55 lakh, in the ratio of 3 Rights Equity Shares for every 13 fully paid-up Equity Shares. Segment Performance: The company operates in a single reportable segment, namely the manufacturing of specialty chemicals and pharmaceutical intermediates. The company states that all other operating activities are incidental to its main business. Labour Code Assessment: The company assessed an incremental impact of Rs 80.94 lakh on its financial results for FY26 under Employee Benefit Expenses due to the notification of the New Labour Codes, primarily arising from changes in the definition of wages and recognition of past service costs. ESOP Allotment: On March 10, 2026, the company allotted 11,750 equity shares to eligible employees under the Dynacons - Employees Stock Option Plan 2020 (ESOP 2020) at an exercise price of Rs 10 per share. Result PDF

• Trendlyne
• 2 weeks 4 days ago